InspireMD to Report Second Quarter 2019 Financial Results and Provide Business Update on Tuesday, August 6

Management to host conference call and webcast at 8am ET

Tel Aviv, Israel— July 30, 2019 – InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of carotid artery disease, announced today that it will host a conference call and webcast on Tuesday, August 6, 2019, to discuss financial results for the second quarter and six months ended June 30, 2019, and provide a corporate update.


Conference Call & Webcast:

Tuesday, August 6th @ 8am Eastern Time

Within the US:                                   877-451-6152

Outside the US:                                 201-389-0879

Conference ID:                                  13692587



About InspireMD, Inc.

InspireMD seeks to utilize its proprietary MicroNet™® technology to make its products the industry standard for treatment of carotid artery disease by providing outstanding acute results and durable stroke free long-term outcomes.


InspireMD’s common stock is quoted on the NYSE American under the ticker symbol NSPR and certain warrants are quoted on the NYSE American under the ticker symbol NSPR.WS.



Investor Contacts:

Craig Shore

Chief Financial Officer

InspireMD, Inc.



Jeremy Feffer

LifeSci Advisors, LLC